COPD

The Pharmacy Times® Chronic Obstructive Pulmonary Disease (COPD) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?

Study: COVID-19 Pandemic Has Made Access to Care More Difficult for Patients with COPD

According to the survey results, 56% of patients with chronic obstructive pulmonary disease reported that COVID-19 has made it difficult for them to receive treatment

2020 Vaccination Recommendations for Patients With Chronic Medical Conditions

In the midst of the COVID-19 pandemic, it is important that individuals who are at higher risk for poor outcomes from infection with vaccine-preventable diseases remain up-to-date with their immunizations.

Consider New Treatment Options for COPD

Pharmacists should familiarize themselves with these therapies to help patients lessen the risk of emergency department visits and hospitalizations.

In the study, more patients with allergies had chronic obstructive pulmonary disease (COPD), which is a known risk factor for severe disease with COVID-19.

Pharmacists Play Important Role in COPD Management

They can help patients improve inhalation technique, ensuring better medication adherence.

Digital Tools for Respiratory Disease Win First Ever NASP Challenge

Digital health tools were a major theme during the first-ever NASP Challenge, comprising 4 of the 5 finalists.

FDA Approves Fluticasone Furoate, Umeclidinium, Vilanterol for Treatment of Asthma

The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.

COPD is Underdiagnosed in Older Adults

Chronic obstructive pulmonary disease may remain undetected due to individuals thinking that the symptoms are a normal sign of aging.

FDA Approves Budesonide/Glycopyrrolate/Formoterol Fumarate for Treatment of Patients With COPD

Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere, AstraZeneca) has been approved by the FDA for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), according to a press release.

New Study Finds Lung Development Connection to COPD in Smokers Versus Non-Smokers

Although COPD often develops as a result of smoking, researchers have long puzzled over why nearly one-third of cases occur in people who never smoked.

Pharmacists’ Role in Tackling Social Determinants of Health

At the first educational session of PQA, the speakers discussed pharmacists’ roles in influencing outcomes associated with social determinants of health in the US population.

Study: COPD Linked to Risk of Lung Cancer in Non-Smokers

During this period, 1834 participants developed lung cancer, of whom 290 had COPD and 1544 did not, according to the researchers.

The Pharmacy Times® COPD condition center provides a source of all the latest clinical information, with articles covering an array of progressive lung diseases, like emphysema, chronic bronchitis, and refractory asthma, as well as the robust pipeline of novel COPD therapies. It also serves as a hub of information and news from the upcoming and ongoing conferences and annual meetings of pulmonologists, including pivotal coverage right from the floor.

Among its other resources are a wealth of videos including interviews with thought leaders and experts in COPD, and moderated Peer Exchange panel discussions about the best practices and key methods for treating complex cases, utilizing the newest therapies, examining the issues and challenges of treating the disease, and much more.